Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Selective effects of long-term glycolytic inhibition on B cells from autoimmune prone mice

ABSTRACT: Selective effects of long-term glycolytic inhibition on B cells from autoimmune prone mice

PROVIDER: PRJNA929976 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23290074.fastq.gz	Fastqsanger.gz
	SRR23290075.fastq.gz	Fastqsanger.gz
	SRR23290076.fastq.gz	Fastqsanger.gz
	SRR23290077.fastq.gz	Fastqsanger.gz
	SRR23290078.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Selective effects of long-term glycolytic inhibition on B cells from autoimmune prone mice

Project description:To determine the metabolic requirements of key autoimmune populations in a spontaneous lupus-prone mouse model, we carried out RNA-seq of BXSB.Cg-Cd8atm1Mak Il15tmImx Yaa (Yaa DKO) mice following glycolytic inhibition with 2-deoxyglucose (2DG). Pre-symptomatic (6-week old) mice were used as controls for symptomatic (10-week old) mice with or without long-term (4-week) treatment with 2DG. As a result, we found that 2DG-mediated glycolytic inhibition preferentially affected gene signatures of activated B cells and not T cells or other immune cell populations.

2024-02-23 | GSE224148 | GEO

MicroRNA profiling by PCR array of mouse Treg cells from non-autoimmune C3H/HeOuj and lupus prone MRL/lpr strains

Project description:Comparison of Treg miRNA expression between non-autoimmune C3H/HeOuj and lupus prone MRL/lpr mice

2011-11-30 | E-MEXP-2954 | biostudies-arrayexpress

gut microbiome and mycobiome of autoimmune-prone advanced intercross mouse line

Project description:gut microbiome and mycobiome of autoimmune-prone advanced intercross mouse line

| PRJNA886734 | ENA

miR-21-dependent gene expression profile of B cells in imiquimod treated autoimmune-prone Sle1b mice

Project description:MicroRNAs (miRNAs) are involved in B cell responses that drive the loss of tolerance in systemic lupus erythematosus (SLE), though the role of many miRNAs remains uncharacterized. Here we studied the role of miR-21 in modulating the transcriptome and function of B cells in imiquimod treated autoimmune-prone Sle1b mice.

2021-09-09 | GSE148285 | GEO

Intersection of Immunity, Metabolism, and Muscle Regeneration in an Autoimmune-Prone MRL Mouse Model

Project description:Intersection of Immunity, Metabolism, and Muscle Regeneration in an Autoimmune-Prone MRL Mouse Model

| PRJNA1060649 | ENA

Short-term hypoxia synergizes with interleukin 15 priming in driving glycolytic gene transcription and supports human natural killer cell activities.

Project description:Natural killer (NK) cells induce apoptosis in infected and transformed cells and produce immunoregulatory cytokines. At this, NK cells operate in inflammatory and tumor environments low in oxygen (hypoxic) and with immunosuppressive properties. In vitro studies of NK cells are, however, commonly performed in ambient air (normoxia). We evaluated the immediate impact of short-term hypoxia on various intrinsic activities of resting and IL-15 primed NK cells and determined underlying transcriptional pathway regulations using a 2 × 2 factorial design. Hypoxia stimulated migration through extracellular matrix, supported secretion of specific chemokines, and shifted amounts of susceptible leukemia target cells toward late apoptosis. IL-15 was a powerful inducer of anabolic gene transcription. Associations of hypoxia with HIF-1 and glycolytic pathways were dependent on priming which represented the largest contrasts observed. Regulatory patterns and RT-PCR validated synergistic hypoxia-IL-15 interactions in upregulation of key glycolytic enzymes suggest an important function for anaerobic glycolysis in priming, underpinning the emerging role of glycolytic switching in driving NK cell function. Adaption to short-term hypoxia appeared however transitory. We conclude that control of oxygen in vitro can promote NK cell features desirable for adoptive transfer therapy.

2016-05-09 | GSE70214 | GEO

HIF1a-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

Project description:Upon antigen stimulation, the bioenergetic demands of T cells increase dramatically over the resting state. Although a role for the metabolic switch to glycolysis has been suggested to support increased anabolic activities and facilitate T cell growth and proliferation, whether cellular metabolism controls T cell lineage choices remains poorly understood. Here we report that the glycolytic pathway is actively regulated during the differentiation of inflammatory TH17 and Foxp3-expressing regulatory T cells (Treg), and controls cell fate determination. TH17 but not Treg-inducing conditions resulted in strong upregulation of the glycolytic activity and induction of glycolytic enzymes. Blocking glycolysis inhibited TH17 development while promoting Treg cell generation. Moreover, the transcription factor hypoxia-inducible factor 1a (HIF1a) was selectively expressed in TH17 cells and its induction required signaling through mTOR, a central regulator of cellular metabolism. HIF1a-dependent transcriptional program was important for mediating glycolytic activity, thereby contributing to the lineage choices between TH17 and Treg cells. Lack of HIF1a resulted in diminished TH17 development but enhanced Treg differentiation, and protected mice from autoimmune CNS inflammation. Our studies demonstrate that HIF1a-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Naïve CD4 T cells from wild-type and HIF1a-deficient mice (in triplicates each group) were differentiated under TH17 conditions for 2.5 days, and RNA was analyzed by microarrays.

2011-06-07 | E-GEOD-29765 | biostudies-arrayexpress

miR-21-dependent gene expression profile of B cells in imiquimod treated autoimmune-prone Sle1b mice

Project description:miR-21-dependent gene expression profile of B cells in imiquimod treated autoimmune-prone Sle1b mice

| PRJNA623734 | ENA

Punctual ablation of Foxp3+ T cells unleashes an autoimmune lesion

Project description:How do Treg cells control an autoimmune lesion? We depleted Foxp3+ Treg cells in autoimmune prone TCR transgenic BDC2.5 mice on the NOD background Kinetic of gene-expression changes in CD4 T cells isolated for pancreas and pancreas draining lymph node (PLN) of Foxp3-DTR.BDC2.5/NOD mice after Treg cell ablation Keywords: T cell activation/ differentiation after Treg depletion timecourse CD4 T cells were isolated from pancreas and PLN at 0, 15 and 24 hours after diphtheria toxin application into 4-6 week old female Foxp3-DTR.BDC2.5/NOD transgenic mice

2009-10-15 | E-GEOD-18136 | biostudies-arrayexpress

Punctual ablation of Foxp3+ T cells unleashes an autoimmune lesion

2009-10-15 | GSE18136 | GEO